3558 results for «221»

Filter By

3558 results

Tricuspid TEER intraprocedural guidance

12 Sep 2025 – From PCR Rio Valves 2025

Master the intraprocedural guidance essential for successful Tricuspid Transcatheter Edge-to-Edge Repair (TEER). This session provides comprehensive insights into pre-procedural analysis, gap measurement techniques, and step-by-step intraprocedural monitoring with expert tips and tricks.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

Management of hostile access for TAVI

11 Sep 2025 – From PCR Rio Valves 2025

Access challenges are among the most critical hurdles in TAVI procedures. This session explores how to identify difficult access routes using pre-procedural CT, and demonstrates practical techniques to safely overcome these obstacles. Through real-life case presentations—including challenging femoral access with a shockwave balloon, carotid access, and...

Management of hostile access for TAVI

Extreme TAVI: bicuspid valves, emergency TAVI, dissections and more

12 Sep 2025 – From PCR Rio Valves 2025

Explore extreme and complex TAVI cases that push procedural limits, including urgent interventions, bicuspid valve sizing, valve-in-valve strategies, and rare complications such as type A dissection and late coronary occlusion. This session shares valuable clinical experiences and lessons from challenging scenarios.

Mitral valve - The role of the echocardiography imager pre and post intervention

11 Sep 2025 – From PCR Rio Valves 2025

This session emphasizes the critical role of echocardiography imaging pre- and post-mitral valve interventions. It includes case-based post-processing with comprehensive transthoracic and transesophageal echocardiography essential for decision-making in mitral TEER, identification and grading of recurrent mitral regurgitation, and evaluations related to mitral annular calcification and valve-in-calcification...

Addressing challenges in the right heart

11 Sep 2025 – From PCR Rio Valves 2025

This session addresses complex challenges associated with right heart conditions, featuring cases such as post-infarction interventricular septal defect with right heart failure, innovative orthotopic options for tricuspid regurgitation, and advanced edge-to-edge repair using the TRICLIP device. Gain insight into therapeutic strategies for managing severe tricuspid insufficiency...

Tricuspid valve - Present and future perspectives: a critical appraisal

12 Sep 2025 – From PCR Rio Valves 2025

Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...

Management of aortic stenosis: what really matters before and after the procedure

11 Sep 2025 – From PCR Rio Valves 2025

Aortic stenosis management is a lifetime strategy, not a one-time procedure. This session covers key decision-making factors, compares surgical and transcatheter options, and provides guidance on post-procedural care. Learn to individualise treatment based on age, anatomy, and risk, and plan interventions with the patient’s long-term trajectory...

Management of aortic stenosis: what really matters before and after the procedure

Structural heart: demanding anatomies, difficult situations and unusual strategies

12 Sep 2025 – From PCR Rio Valves 2025

Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...

Problem-solving in challenging TAVI cases

11 Sep 2025 – From PCR Rio Valves 2025

Explore complex and challenging TAVI cases with expert-led discussions covering redo TAVI procedures, horizontal aorta anatomy, rapid pacing protocols, lithotripsy-assisted interventions for severe calcific stenosis, and management of procedural complications including valve dislodgement.

Advanced TAVI: techniques, timing, and problem-solving

12 Sep 2025 – From PCR Rio Valves 2025

Advance your knowledge in TAVI with this session addressing sophisticated techniques, procedural timing, and problem-solving in complex cases. Explore TAVI applications in rare quadricuspid valve anatomy with pure aortic insufficiency, strategic decision-making between TAVI and PCI, and innovative solutions for managing aortic stenosis in patients with...

Redefining and optimising LAA closure - LIVE Case

11 Sep 2025 – From PCR Rio Valves 2025

Experience a LIVE educational case from University Hospitals Harrington Heart & Vascular Institute demonstrating a minimalist approach to left atrial appendage (LAA) closure. Learn about the use of intracardiac echocardiography, conscious sedation, and local anaesthesia to improve safety and efficiency, along with patient selection, imaging integration,...

Redefining and optimising LAA closure - LIVE Case

The complexity of transcatheter tricuspid valve interventions

11 Sep 2025 – From PCR Rio Valves 2025

Understand the complexities of transcatheter tricuspid valve interventions through diverse case studies addressing challenging clinical scenarios. Learn about therapeutic alternatives including TEER with pacemaker leads, imaging challenges with ICE, transcatheter tricuspid valve replacement with Evoque and LuxValve devices, and straightforward options like TricValve. Gain perspective on...

The complexity of transcatheter tricuspid valve interventions

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Pamela Gatto

Author

Pamela Gatto
Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

26 Jan 2024

Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.

Authors :

Juan Guzmán Olea, Gonzalo Tolosa Dzul, Beatriz Villegas González, Jonathan Uribe González,  Guillermo Arenas Fonseca, Tomás Herrera Arzola, Rosa Gutiérrez Castañeda, Víctor Sustaita Cerda, Raúl Cruz Palomera, Arely Méndez Mercado, Darío Valencia González, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez, Gabriel Guzmán Olea.Specialty Hospital, Puebla, IMSS, México
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!

17 Oct 2020

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.

Author

Hector Garcia
Live from TCT Connect 2020: PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB
Didn’t find what you were looking for?